Studies

ALCOHOL USE DISORDER

SPONSOR: Eli Lilly and Company

STUDY NAME: A Study of Brenipatide in Participants With Alcohol Use Disorder (RENEW-ALC-2)

LINK: https://clinicaltrials.gov/study/NCT07219953

SPONSOR: Eli Lilly and Company

STUDY NAME: A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)

LINK: https://www.clinicaltrials.gov/study/NCT07219966

Generalized Anxiety disorder

SPONSOR: Definium Therapeutics

STUDY NAME: A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

LINK: https://www.clinicaltrials.gov/study/NCT06809595

Major Depressive Disorder

SPONSOR: atai Therapeutics, Inc.

STUDY NAME: A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

LINK: https://clinicaltrials.gov/study/NCT06524830

SPONSOR: Cybin IRL Limited

STUDY NAME: Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) (EXTEND)

LINK: https://clinicaltrials.gov/study/NCT06605105

SPONSOR: Draig Therapeutics Ltd

STUDY NAME: A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression (Tarian-1)

LINK: https://clinicaltrials.gov/study/NCT07300969

SPONSOR: Eli Lilly and Company

STUDY NAME: A Study to Investigate Adjunctive Treatment with Brenipatide Compared with Placebo in Delaying Time to Relapse in Adult Participants with Major Depressive Disorder (RENEWMDD-1)

LINK: Not Available

SPONSOR: Janssen Research & Development, LLC

STUDY NAME: A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)

LINK: https://clinicaltrials.gov/study/NCT07258485

SPONSOR: Neumora Therapeutics, Inc.

STUDY NAME: Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

LINK: https://clinicaltrials.gov/study/NCT06058039

SPONSOR: Syndeio Biosciences, Inc

STUDY NAME: GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia

LINK: https://clinicaltrials.gov/study/NCT07115329

Opioid Use Disorder

SPONSOR: Eli Lilly and Company

STUDY NAME: A Study to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Buprenorphine with or without Naloxone in Early Recovery of Participants with Opioid Use Disorder (RENEW-Op-1)

LINK: Not Available

SPONSOR: Merck Sharp & Dohme LLC

STUDY NAME: A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

LINK: https://www.clinicaltrials.gov/study/NCT06655883

Schizophrenia

SPONSOR: Bristol-Myers Squibb

STUDY NAME: A Study to Evaluate the Effect of KarXT on Urological Safety

LINK: https://clinicaltrials.gov/study/NCT07221877

SPONSOR: Eli Lilly and Company

STUDY NAME: A Study of Adjunctive Treatment with Brenipatide Compared to Placebo in Adult Participants with Schizophrenia (RENEW-Scz-1)

LINK: Not Available

SPONSOR: MapLight Therapeutics

STUDY NAME: A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

LINK: https://clinicaltrials.gov/study/NCT07038876

SPONSOR: Neurocrine Biosciences

STUDY NAME: NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

LINK: https://www.clinicaltrials.gov/study/NCT06963034

SPONSOR: Neurocrine Biosciences

STUDY NAME: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

LINK: https://clinicaltrials.gov/study/NCT07114874